Diagnosis of Cystic Fibrosis-related Diabetes: Too Early or Too Late?

Overview

Journal J Bras Pneumol

Specialty Pulmonary Medicine

Date 2022 Apr 27

PMID 35475871

Authors

Aleksandar Sovtic

Affiliations

Soon will be listed here.

Citing Articles

An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents.

Anton-Paduraru D, Murgu A, Donos M, Trofin F, Azoicai A, Popovici P Children (Basel). 2023; 10(12).

PMID: 38136081 PMC: 10741586. DOI: 10.3390/children10121879.

References

Zorron M, Marson F, Morcillo A, Goncalves A, El Beck M, Ribeiro J . Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?. J Bras Pneumol. 2022; 48(2):e20210307. PMC: 9064635. DOI: 10.36416/1806-3756/e20210307. View

Moran A, Brunzell C, Cohen R, Katz M, Marshall B, Onady G . Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010; 33(12):2697-708. PMC: 2992215. DOI: 10.2337/dc10-1768. View

Gojsina B, Minic P, Todorovic S, Soldatovic I, Sovtic A . Continuous Glucose Monitoring as a Valuable Tool in the Early Detection of Diabetes Related to Cystic Fibrosis. Front Pediatr. 2021; 9:659728. PMC: 8298893. DOI: 10.3389/fped.2021.659728. View

Prentice B, Ooi C, Verge C, Hameed S, Widger J . Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis. J Cyst Fibros. 2020; 19(5):700-703. DOI: 10.1016/j.jcf.2020.02.009. View

Moran A, Pillay K, Becker D, Granados A, Hameed S, Acerini C . ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2018; 19 Suppl 27:64-74. DOI: 10.1111/pedi.12732. View

Chan C, Vigers T, Pyle L, Zeitler P, Sagel S, Nadeau K . Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline. J Cyst Fibros. 2018; 17(6):783-790. PMC: 6151303. DOI: 10.1016/j.jcf.2018.03.008. View

Colombo C, Foppiani A, Bisogno A, Gambazza S, Dacco V, Nazzari E . Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion. J Endocrinol Invest. 2021; 44(10):2213-2218. PMC: 8421269. DOI: 10.1007/s40618-021-01525-4. View

Terliesner N, Vogel M, Steighardt A, Gausche R, Henn C, Hentschel J . Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function. J Pediatr Endocrinol Metab. 2017; 30(8):815-821. DOI: 10.1515/jpem-2017-0005. View

Granados A, Chan C, Ode K, Moheet A, Moran A, Holl R . Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis. J Cyst Fibros. 2019; 18 Suppl 2:S3-S9. DOI: 10.1016/j.jcf.2019.08.016. View

10.

Mainguy C, Bellon G, Delaup V, Ginoux T, Kassai-Koupai B, Mazur S . Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?. J Pediatr Endocrinol Metab. 2016; 30(1):27-35. DOI: 10.1515/jpem-2016-0184. View